Trials / Completed
CompletedNCT02470741
Pilot of Letrozole for Uterine Myomas
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- University of California, San Francisco · Academic / Other
- Sex
- Female
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
PLUM evaluates the drug letrozole as a treatment for uterine fibroids. This study is a randomized, blinded, placebo-controlled trial of oral letrozole among premenopausal women with symptomatic uterine fibroids. Participants will be randomly assigned in a 1:1 ratio to either oral letrozole 2.5mg/day for 6 months (Group A) or intermittent dosing with letrozole 2.5mg/day and an identical placebo capsule (Group B).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Letrozole | |
| OTHER | Placebo |
Timeline
- Start date
- 2015-07-01
- Primary completion
- 2017-12-01
- Completion
- 2017-12-01
- First posted
- 2015-06-12
- Last updated
- 2019-11-15
- Results posted
- 2019-02-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02470741. Inclusion in this directory is not an endorsement.